Xin Lu

28PUBLICATIONS

84CO-AUTHORS

Molecular targetsInnate immunityPredictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (28)

Sort by Publication Date:

|Jul 01, 2026

Synthetic essentiality of TRAIL/TNFSF10 in VHL-deficient renal cell carcinoma.

|Jun 16, 2026

Programmable mRNA 3'UTR engineering restores MHC-I and overcomes immune evasion in prostate cancer.

|Dec 03, 2025

CDH3 as a Novel Therapeutic Target in Basal-like Double-Negative Prostate Cancer.

Guoqiang Liu, Shiyu Wang, Loan Duong

|Nov 24, 2025

An oncogenotype-immunophenotype paradigm governing the myeloid landscape in genetically engineered mouse models of prostate cancer.

Yuting Zhang, Yaoyin Li, Dailin Gan

|Sep 13, 2025

Current Role and Future Frontiers of Spatial Transcriptomics in Genitourinary Cancers.

Firas Hatoum, Adnan Fazili, Justin W Miller

|Jul 30, 2025

Hsp90 <i>pan</i> and Isoform-Selective Inhibitors as Sensitizers for Cancer Immunotherapy.

Shiying Jia, Neeraj Maurya, Brian S J Blagg

Pageof 5

Frequent Collaborators

Dailin Gan

Jun Wan

Philippe E Spiess

Jun Li

Jianping He

Xuechun Wang

Zachary T Schafer

Yini Zhu

Leng Han

Yibin Kang

Frequent Collaborators

Dailin Gan

Jun Wan

Philippe E Spiess

Jun Li